Conestoga Capital Advisors LLC Raises Stock Position in Stevanato Group S.p.A. $STVN

Conestoga Capital Advisors LLC increased its position in shares of Stevanato Group S.p.A. (NYSE:STVNFree Report) by 7.6% during the first quarter, HoldingsChannel.com reports. The fund owned 8,491,751 shares of the company’s stock after acquiring an additional 602,050 shares during the period. Stevanato Group makes up approximately 2.3% of Conestoga Capital Advisors LLC’s holdings, making the stock its 18th largest holding. Conestoga Capital Advisors LLC’s holdings in Stevanato Group were worth $116,762,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of STVN. First Bank & Trust lifted its position in Stevanato Group by 5.6% in the 4th quarter. First Bank & Trust now owns 17,109 shares of the company’s stock worth $344,000 after buying an additional 904 shares during the last quarter. GW&K Investment Management LLC boosted its stake in Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares in the last quarter. Pathstone Holdings LLC grew its position in Stevanato Group by 1.5% during the third quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock valued at $1,833,000 after acquiring an additional 1,067 shares during the last quarter. Mariner LLC raised its stake in shares of Stevanato Group by 6.9% during the third quarter. Mariner LLC now owns 25,447 shares of the company’s stock worth $655,000 after acquiring an additional 1,638 shares in the last quarter. Finally, Diversified Trust Co. raised its stake in shares of Stevanato Group by 12.5% during the fourth quarter. Diversified Trust Co. now owns 16,200 shares of the company’s stock worth $326,000 after acquiring an additional 1,800 shares in the last quarter.

Insiders Place Their Bets

In other Stevanato Group news, Director William J. Federici sold 1,493 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the completion of the sale, the director owned 26,991 shares in the company, valued at approximately €461,276.19. This trade represents a 5.24% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Karen Flynn sold 1,493 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the completion of the sale, the director owned 5,757 shares of the company’s stock, valued at approximately €98,387.13. This trade represents a 20.59% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 5,972 shares of company stock valued at $102,061 over the last three months. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. KeyCorp cut their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, March 5th. Citigroup decreased their target price on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research report on Thursday, March 5th. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, June 18th. TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Finally, Wolfe Research assumed coverage on Stevanato Group in a research note on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective on the stock. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

View Our Latest Research Report on Stevanato Group

Stevanato Group Trading Up 0.1%

NYSE:STVN opened at €18.35 on Thursday. The firm has a market capitalization of $5.56 billion, a P/E ratio of 31.11, a P/E/G ratio of 1.66 and a beta of 0.78. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. The company has a fifty day moving average of €17.61 and a 200 day moving average of €17.16. Stevanato Group S.p.A. has a 52 week low of €12.89 and a 52 week high of €28.00.

Stevanato Group (NYSE:STVNGet Free Report) last announced its quarterly earnings results on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The firm had revenue of €273.57 million during the quarter. During the same quarter in the previous year, the business posted $0.10 earnings per share. The firm’s revenue was up 6.6% on a year-over-year basis. On average, research analysts predict that Stevanato Group S.p.A. will post 0.68 earnings per share for the current year.

Stevanato Group Cuts Dividend

The firm also recently announced an annual dividend, which will be paid on Wednesday, July 29th. Investors of record on Thursday, June 11th will be paid a $0.054 dividend. The ex-dividend date of this dividend is Thursday, June 11th. This represents a dividend yield of 31.0%.

Stevanato Group Profile

(Free Report)

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

Featured Stories

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVNFree Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.